Yoon Hang "John" Kim, MD - Treating chronic pain with low dose naltrexone and ultra low dose naltrexone (2019 Conference) (LDN, low dose naltrexone)

Ted Cole, DO - The Use of LDN and Amino Acids in Parkinson's Disease (2019 Conference) (LDN, low dose naltrexone)

LDN 2019 Conference - Sunday Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Scott Zashin, MD - Treatment of Sjogren's Syndrome with LDN (2019 Conference) (LDN, low dose naltrexone)

LDN 2019 Conference - Saturday Afternoon Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

LDN 2019 Conference - Saturday Morning Q&A (2019 Conference) (LDN, low dose naltrexone)

Presentations on the below and questions were asked in relation to:

Sarah Zielsdorf, MD, MS - Traumatic Brain Injury: Low Dose Naltrexone and Microglial Modification (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD, MS - Graves' Disease (2019 Conference) (LDN, low dose naltrexone)

Sarah Zielsdorf, MD discusses what Graves’ disease is, treatment strategies, related conditions and predisposing factors, and the work-up from a functional medicine standpoint

Sarah Zielsdorf, MD, MS - "Just try LDN": 3 years of insight from over 1000 patients' use of Low Dose Naltrexone (2019 Conference) (LDN, low dose naltrexone)

Samyadev Datta, MD - Pharmacology of Low dose Naltrexone in Chronic Pain Management (2019 Conference) (LDN, low dose naltrexone)

Samyadev Datta, MD discusses LDN and ultra-low dose naltrexone (ULDN) to treat chronic pain and inflammatory/autoimmune conditions. He presents on the history and pharmacology of naltrexone, forms in which LDN can be prepared. Several case studies on pain are presented